- Home
- Applications
- usa massachusetts
- chronic obstructive pulmonary disease
Show results for
Refine by
Chronic Obstructive Pulmonary Disease Product Applications In Usa Massachusetts
5 applications found
For many years, researchers have investigated cell and gene therapies as potential replacement therapies for severe chronic diseases. Despite major advancements in the field, these approaches carry a number of limitations including immune rejection, limited eligibility, durability and variability challenges, inability to re-dose and high manufacturing costs. To address these drawbacks, we developed our novel Shielded Living Therapeutics™ (SLTx) platform, which we believe has the potential to result in ...
ByEli Lilly and Company based in Indianapolis, INDIANA (USA)
Bipolar disorder, also known as manic-depressive illness, is a brain disorder that causes unusual shifts in a person’s mood, energy, and ability to function. Different from the normal ups and downs that everyone goes through, the symptoms of bipolar disorder are severe. They can result in damaged relationships, poor job or school performance, and even suicide. About 5.7 million American adults or about 2.6 percent of the population aged 18 and older in any given year, have bipolar ...
ByBrainsWay Ltd. based in Burlington, MASSACHUSETTS (USA)
Alzheimer’s disease is a major cause of severe cognitive decline in the aged. The primary cognitive deficiencies are revealed in working memory, language, executive functions, attention, and long-term ...
ByBrainsWay Ltd. based in Burlington, MASSACHUSETTS (USA)
Type 1 diabetes is a common chronic disease, affecting millions of people throughout the world, in which the immune system attacks the body’s own pancreatic cells, stopping the production of insulin. Though it was previously considered a childhood disease, type 1 diabetes is known to affect people at every age, and it has no ...
ByEli Lilly and Company based in Indianapolis, INDIANA (USA)
ViTrack is a platform technology with applications across the continuum of care. In 2015, with the support of MIT and Tufts, the founding team behind Dynocardia began their search for a fundamentally different approach to the measurement of blood pressure (BP) that can measure automatically, without the participation of the user, caregiver, or healthcare provider. After rigorous bench testing and ongoing clinical studies in the ICU, ViTrack technology is proven to offer accurate continuous, non-invasive blood ...
ByDynocardia, Inc. based in Cambridge, MASSACHUSETTS (USA)